Pierre-Olivier Goineau
Vorstandsvorsitzender bei StromaCare SAS
Aktive Positionen von Pierre-Olivier Goineau
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SCI Du Grand Tambour | Corporate Officer/Principal | - | - |
Goineau Développement & Finance SASU
Goineau Développement & Finance SASU Miscellaneous Commercial ServicesCommercial Services Goineau Développement & Finance SASU provides business and management consulting services. The company was founded on March 27, 2015 and is headquartered in Lyon, France. | Vorsitzender | 02.04.2015 | - |
NEURONAX SA
NEURONAX SA Pharmaceuticals: MajorHealth Technology NEURONAX SA develops and provides drugs supporting neural repair to treat degenerative disorders of the central nervous system. Its services include cell culture, in vitro evaluation, neurotrophic and neuroprotective effects analysis, culture analyses, and stem cells. The company was founded by Stéphane Gobron, Fabrice Cailloux, and Pierre-Yves Simonin in 2003 and is headquartered in Saint-Beauzire, France. | Direktor/Vorstandsmitglied | - | - |
Sofimac Innovation SAS
Sofimac Innovation SAS Investment ManagersFinance Sofimac Innovation SAS is an independent, early-stage venture capital firm which was created in 1998 by Eric Harlé and Didier Moret. Headquartered in Paris, France, Sofimac Innovation manages venture capital funds which provide equity financing for start-ups and early-stage companies in the Information and Communication Technologies (Software, SaaS, Multimedia and Telecom) sector. | Private Equity Investor | 01.11.2013 | - |
StromaCare SAS
StromaCare SAS Miscellaneous Commercial ServicesCommercial Services StromaCare SAS is a company based in Lyon, France that is dedicated to developing innovative oncology drugs for the treatment of solid tumors. The French company's strategy is to identify molecules overexpressed in the tumoral stroma and involved in immune-suppression, which leads to new therapeutic avenues. StromaCare's scientific rationale and therapeutic candidate are based on the modulation of stromal components. The company was founded by Pierre-Olivier Goineau and Ana Hennino, with Pierre-Olivier Goineau serving as CEO since incorporation. | Vorstandsvorsitzender | 01.04.2021 | - |
Gründer | - | - |
Karriereverlauf von Pierre-Olivier Goineau
Ehemalige bekannte Positionen von Pierre-Olivier Goineau
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ERYTech Pharma SA
ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | Direktor/Vorstandsmitglied | 22.11.2004 | 08.01.2015 |
Geschäftsführer | 22.11.2004 | 08.01.2015 | |
Gründer | 01.12.2009 | 08.01.2015 | |
Investor Relations Kontakt | 22.11.2004 | 08.01.2015 | |
Präsident | 25.10.2010 | - | |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Direktor/Vorstandsmitglied | 06.08.2010 | 12.06.2014 |
Vorsitzender | 12.06.2014 | - |
Ausbildung von Pierre-Olivier Goineau
University of Lyon | Graduate Degree |
Statistik
International
Frankreich | 9 |
Operativ
Director/Board Member | 3 |
Founder | 2 |
Chairman | 2 |
Sektoral
Commercial Services | 4 |
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 7 |
---|---|
ERYTech Pharma SA
ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | Health Technology |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Commercial Services |
SCI Du Grand Tambour | |
Goineau Développement & Finance SASU
Goineau Développement & Finance SASU Miscellaneous Commercial ServicesCommercial Services Goineau Développement & Finance SASU provides business and management consulting services. The company was founded on March 27, 2015 and is headquartered in Lyon, France. | Commercial Services |
NEURONAX SA
NEURONAX SA Pharmaceuticals: MajorHealth Technology NEURONAX SA develops and provides drugs supporting neural repair to treat degenerative disorders of the central nervous system. Its services include cell culture, in vitro evaluation, neurotrophic and neuroprotective effects analysis, culture analyses, and stem cells. The company was founded by Stéphane Gobron, Fabrice Cailloux, and Pierre-Yves Simonin in 2003 and is headquartered in Saint-Beauzire, France. | Health Technology |
Sofimac Innovation SAS
Sofimac Innovation SAS Investment ManagersFinance Sofimac Innovation SAS is an independent, early-stage venture capital firm which was created in 1998 by Eric Harlé and Didier Moret. Headquartered in Paris, France, Sofimac Innovation manages venture capital funds which provide equity financing for start-ups and early-stage companies in the Information and Communication Technologies (Software, SaaS, Multimedia and Telecom) sector. | Finance |
StromaCare SAS
StromaCare SAS Miscellaneous Commercial ServicesCommercial Services StromaCare SAS is a company based in Lyon, France that is dedicated to developing innovative oncology drugs for the treatment of solid tumors. The French company's strategy is to identify molecules overexpressed in the tumoral stroma and involved in immune-suppression, which leads to new therapeutic avenues. StromaCare's scientific rationale and therapeutic candidate are based on the modulation of stromal components. The company was founded by Pierre-Olivier Goineau and Ana Hennino, with Pierre-Olivier Goineau serving as CEO since incorporation. | Commercial Services |
- Börse
- Insiders
- Pierre-Olivier Goineau
- Erfahrung